HMGB1 and neoplasm: Following TAK-242 treatment to inhibit TLR4 signaling, the HMGB1-induced M1 macrophage polarization stimulated with the supernatants from ADVNE− or ADVPPE-treated tumor cells was abrogated (Fig. 6H and Fig. S6A).